Early initiation of prostate-specific antigen (PSA) screening in Black men would reduce prostate cancer deaths by about 30% without a significant increase in overdiagnosis, according to new screening guidelines from the Prostate Cancer Foundation. Black men in the US are at a high risk of getting diagnosed and dying from prostate cancer. Recently, the Prostate Cancer Foundation released Six guideline statements for prostrate cancer screening targeted at Black men. ...
Disparities in Prostate Cancer
Advertisement
"Prostate cancer cells (are) producing more cholesterol, which they divert to generate their own androgen."
Black participants were significantly less likely to use NHT compared to other racial and ethnic groups.
Researchers found that men from indigenous men were more likely to have higher PSA compared to non-Indigenous men.
Asian PCa patients had longer median overall survival than White patients.
Approximately 30% - 40% of the variation in PSA is "noise" that isn't cancerous but determined by genetics.
Black individuals are more likely to believe videos about prostate cancer when Black physicians or patients present it.
Men with a BMI of 30 or higher were less likely to screen positive for either the PSA test or DRE.
American Indian and Alaska Native men are less likely to get PSA testing and DREs for prostate cancer screening.
Advertisement
Expert Interviews
Quinton Maidment, Vice President of The Bliss Group explains the steps involved in clinical trial enrollment process.
Dr. Charlotte Owens talks societal impact of unplanned pregnancy and contraceptive deserts plus Her Plan is Her Power
Dr. Rachel Freedman of Dana-Farber Cancer Institute is joined by colleagues to discuss barriers of cancer in breast cancer.
The board-certified family practice physician discusses age management medicine, including strategies for managing weight.
Adrelia Allen, PharmD, discusses the urgent push for diversity in clinical trials.
Andrew Hertler, MD, talks about the importance of prophylactic mastectomy for individuals carrying high-risk gene mutations.
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
